Predictive biomarkers for outcome and subtype of ischemic stroke

Takeaway

  • Immune cell counts and C-reactive protein (CRP) level may be useful predictive biomarkers for ischemic stroke outcomes, including death and functional outcomes defined by the National Institute of Health Stroke Scale/Score (NIHSS), the modified Rankin Scale for Neurologic Disability (mRS), and the Barthel Index (BI) score.

Why this matters

  • Several risk factors – including hypertension, dyslipidemia and atrial fibrillation as well as cigarettes smoking, alcohol and diabetes – are known to be associated with increased risk of stroke, but do not account for the totality of stroke incidence. Recently, chronic inflammation has been proposed as an additional important risk factor.

  • A thorough investigation of what chronic inflammatory biomarkers or risk factors could help to predict mortality and functional outcomes in ischemic stroke is lacking.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.